SAHIN UGUR has a total of 44 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, Germany and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are BIONTECH AG, LUDWIG INST CANCER RES and GANYMED PHARMACEUTICALS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 41 | |
#2 | Germany | 2 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Computer technology | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Bioinformatics | |
#9 | Climate change adaptation technologies | |
#10 | Computational chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Sahin Ugur | 43 |
#2 | Koslowski Michael | 28 |
#3 | Tureci Ozlem | 21 |
#4 | Türeci Özlem | 9 |
#5 | Tuereci Oezlem | 9 |
#6 | Usener Dirk | 8 |
#7 | Omokoko Tana | 4 |
#8 | Walter Korden | 4 |
#9 | Brandenburg Gunda | 4 |
#10 | Fritz Stefan | 3 |
Publication | Filing date | Title |
---|---|---|
DE10211088A1 | Gene products differentially expressed in tumors and their use | |
DE10108626A1 | Procedure for the identification of biologically active structures of microbial pathogens |